Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BNT411 |
Trade Name | |
Synonyms | BNT 411|BNT-411 |
Drug Descriptions |
BNT411 is a TLR7 agonist, which activates B cells and CD8-positive T-lymphocytes as well as innate immune cells, potentially resulting in antitumor activity (NCI Drug Dictionary). |
DrugClasses | TLR7 Agonist 12 |
CAS Registry Number | NA |
NCIT ID | C167350 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + BNT411 + Carboplatin + Etoposide | Atezolizumab BNT411 Carboplatin Etoposide | 0 | 1 |
BNT411 | BNT411 | 0 | 1 |